ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628141 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628141; 2) Community: the network communities that were significantly associated with the response to NSC 628141; 3) Molecule: the relationships between components within communities and NSC 628141; 4) MDR: the compounds that were significantly associated with the NSC 628141.

NSC Compound Enrichment Correlation
NSC 634035 4-amino-3-iodo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one 0.00176785174089478 0.1139097
NSC 672131 Null 0.00176785174089478 0.34465264
NSC 679002 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl]-, diethyl ester, cis- 0.00176785174089478 0.16053687
NSC 697859 Null 0.00176785174089478 0.2523117
NSC 724780 (1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 0.00176785174089478 0.16462173
NSC 681642 Camptothecin Derivative 0.00216000169440199 0.086723311
NSC 692313 Null 0.00216000169440199 0.46987731
NSC 693634 Null 0.00216000169440199 0.076800505
NSC 709437 Null 0.00216000169440199 0.36835862
NSC 744076 Null 0.00216000169440199 0.12213466
Total:99  Current:9    [First] [Prev] [Next] [Last]